News and Announcements
MedAdvisor Partners with Asthma Australia
- Published November 29, 2016 4:02PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
29th November 2016, ASX Announcement
- MedAdvisor partners with Asthma Australia, Australia’s peak body supporting people with asthma and their carers
- Partnership aims to improve health outcomes for the estimated 2.4 million (1 in 10) Australians living with asthma, via the MedAdvisor platform
- High priority health cost reduction area: total cost of asthma in Australia is estimated to be $28 billion per annum with $1.1 billion directly related to productivity costs
- Further builds on MedAdvisor’s health association partnerships that play a key role in driving patient awareness of MedAdvisor
- In line with the Company’s strategy to enhance health outcomes for the 11m Australians living with chronic conditions and lower costs associated with poor medication adherence
MedAdvisor Limited (ASX: MDR, the Company), Australia’s leading digital medication adherence company, is pleased to announce it has entered into a partnership with not-for-profit health association Asthma Australia. The partnership will run for an initial period of 12 months.
To view the full announcement, please click on the button below.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
